Post operative complications of double-J ureteral stenting: a prospective study

Noopur Bansal, Gurpreet Singh Bhangu, Darpan Bansal


Background: Placement of indwelling ureteral stents has become routine in the management of variety of urinary tract infections. Despite the advances and technology, the ideal stent is not available yet. A double-J stent is never without potential complications which may be minor in form of hematuria, dysuria, frequency, flank and suprapubic pain to major complications such as vesicoureteric reflux, migration, malposition, encrustation, stent fracture etc.

Methods: One hundred urological patients who had undergone double-J ureteral stenting attending surgery department were taken. Patients were subjected to detailed history and clinical examination and other routine investigations and symptoms of any complications were recorded starting at the time of placement of double-J ureteral stent till its removal.

Results: Majority of the patients in our study had only minor complications related to double-J ureteral stenting like flank or suprapubic pain, dysuria, hematuria and urgency which were managed conservatively. Major complication like stent migration was seen only in 1 patient which was managed with removal of stent.

Conclusions: At the end of study, we concluded that double-J stents have become an essential part of many endourological and open urological procedures and their use cannot be completely avoided.


Double-J ureteral stent, Post-operative complications, Stent migration, Haematuria

Full Text:



Monga M. Ureteral Stents: New materials and designs. In: Williams JC, Evansa A, Lingeman J, editors. Renal Stone Disease. 2nd ed. Melville NY, American Institute of Physics; 2008: 173-181.

Chew BH, Knudsen BH, Denstedt D. The use of stent in contemporary urology. Curr Opin Urol. 2004;14:111-5.

Jeong H, Hawk C, Lee SE. Ureteric stenting after ureteroscopy for ureteric stones: a prospective randomized study assessing symptoms and complications. BJU Int. 2004;93:1032-5.

Knudsen BE, Beiko DT, Denstedt JD. Stenting after ureteroscopy: pros and cons. Urol Clin N Am. 2004;31:173-80.

Joshi HB, Okeke A, Newns N, Keeley FX Jr, Timoney AG. Characterisation of urinary symptoms in patients with ureteral stents. Urology. 2002;59:511-9.

Byrne RR, Auge BK, Kourambas J. Routine ureteral stenting is not necessary after ureteroscopy and ureteropyeloscopy: a randomized controlled trial. J Endourol. 2002;16:9-13.

Hao P, Li W, Song C, Yan J, li L. Clinical evaluation of double-pigtail in patients with upper urinary tract diseases: Report of 2685 cases. J Endourol. 2008;22:65-70.

Thomas R. Indwelling ureteral stents: Impact of material and shape on patient comfort. J Endourol. 1993;7:137-40.

Sur RL, Haleblian GE, Cantour D, Springhart P, Albala D, Preminger G. Efficacy of intravesical rupivacaine injection onurinary symptoms following ureteral stenting: a randomized controlled study. J Endourol. 2008;22:473-8.

Rane A, Saleemi A, Cahill D, Sriprasad S, Shrotri N, Tiptaft R. Have stent-related symptoms anything to do with placement technique? J Endourol. 2001;15:741-4.

Smedely FH, Rimmer J, Taube M. Double J (pigtail) ureteric catheter insertions: A retrospective review. Ann R Coll Surg Engl. 1988;70:377-9.

Ramsay JW, Payne SR, Gosling PT, Whitfield HN, Wickman JE, Levison DA. Effects of double-j stenting on unobstructed ureter: an experimental and clinical study. Br J Urol. 1985;57:630-4.

Mosli H, Farsi H, al-Zemaity MF, Saleh TR, al-Zamzami MM. Vesicoureteral reflux in patients with double pigtail stents. J Urol. 1991;146:966-9.

Ho CH, Chen SC, Chung SD, Lee YJ, Chen J, Yu HJ, et al. Determining the appropriate length of double-pigtail ureteral stent by both stent configuration and related symptoms. J Endourol. 2008;22:1427-31.

Saltzman B. Ureteral stents: indications, variations and complications. Urol Clin N Am. 1988;15:481-91.

Breau RH, Norman RW. Optimal prevention and management of proximal ureteral migration and remigration. J Urol. 2001;166:890-3.

Staton JW, Kropp KA. Proximal ureteral stent migration: an avoidable complication? J Urol. 1996;155:58-61.

Mitty HA. Stenting of the ureter. In: Pollack HM, McClennan BL, eds. Clinical urography. 2nd ed. Philadelphia, PA: Sanduars; 2000: 3186-3205.

Mardis HK, Kroger RM. Ureteral stents: materials. Uro Clin North Am. 1988;15:471-9.

Zisman A, Siegel YI, Siegmann A, Lindner A. Spontaneous ureteral stent fragmentation. J Urol. 1995;153:718-21.

Witjes JA. Breakage of silicon double pigtail ureteral stent as a long term complication. J Urol. 1993;150:1898-9.

Nawaz H, Hussain M, Hashmi A, Hussain Z, Zafar N, Naqvi A, et al. Experience with indwelling JJ ureteral stents. JPMA. 1993;43(8):147-9.

Saltzman B. Ureteral stents. Indications, variations, and complications. Urol Clin N Am. 1988;15(3):481-91.

Memon NA, Talpur AA, Memon JM. Indications and complications of indwelling ureteral stenting at NMCH, Nawabshah. Pak J Surg. 2007;23(3):187-91.

Ghaffar A. DJ-Stenting; Efficacy in the management of obstructive uropathy. Professional Med J. 2007;14:56-9.

Lawrentschuk N, Russel JM. Ureteric stenting 25 years on: Routine or risky?. ANZ J Surg. 2004;74:243-7.

Deliveliotis C, Chrisofos M, Gougousis E, Papatsoris A, Dellis A, Varkarakis IM. Is there a role for alpha1-blockers in treating double-J stent-related symptoms?. Urol. 2006;67:35-9.

Damiano R, Oliva A, Esposito C, De Sio M, Autorino R, D’Armiento M. Early and late complications of double pigtail ureteral stent. Urol Int. 2002;69(2):136-40.

Pansota MS, Rasool M, Saleem MS, Tabassum SA, Hussain A. Indications and complications of double J ureteral stenting: our experience. Gomal J Med Sci. 2013;11(1):8-12.

Singh I. Indwelling JJ ureteral stents - a current perspective and review of literature. Indian J Surg. 2003;65:405-12.

Gorman SP, Tunney MM, Keane PF, Van Bladel K, Bley B. Characterization and assessment of a novel poly (ethylene oxide)/polyurethane composite hydrogel (Aquavene®) as a ureteral stent biomaterial. J Biomed Materials Res. 1998;39(4):642-9.

Riedl CR, Witkowski M, Plas E, Pflueger H. Heparin coating reduces encrustation of ureteral stents: a preliminary report. Int J Antimicrobial Agents. 2002;19(6):507-10.

Watterson JD, Cadieux PA, Beiko DT, Cook AJ, Burton JP, Harbottle RR, et al. Oxalate-degrading enzymes from Oxalobacter formigenes: a novel device coating to reduce urinary tract biomaterial-related encrustation. J Endourol. 2003;17(5):269-74.

Zupkas P, Parsons CL, Percival C, Monga M. Pentosanpolysulfate coating of silicone reduces encrustation. J Endourol. 2000;14(6):483-8.

Bultitude MF, Tiptaft RC, Glass JM, Dasgupta P. Management of encrusted ureteral stents impacted in upper tract. Urol. 2003;62(4):622-6.

Arshad M, Shah SS, Abbasi MH. Applications and complications of polyurethane stenting in urology. J Ayub Med Coll Abbottabad. 2006;18(2):69-72.